IGF-1 exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats

NEUROSCIENCE LETTERS

卷:425

Article

Escartin, Carole ; Boyer, Frederic ; Bemelmans, Alexis-Pierre ; Hantraye, Philippe ; Brouillet, Emmanuel

关键词: IGF-1;    neuroprotection;    Huntington's disease;    3-nitropropionic acid;    mitochondrial impairment;    striatum;   

DOI  :  10.1016/j.neulet.2007.08.031

来源: Elsevier

【 摘 要 】

Insulin-like Growth Factor 1 (IGF-1) has broad-range neuroprotective effects and is a therapeutic candidate for Huntington's disease (HD). IGF-1 protects striatal neurons from the toxicity of mutated huntingtin in vitro and improves neuronal survival in vivo in a phenotypic model of HD involving excitotoxic cell death. Because HD is a multifactorial disease, it is important to evaluate the neuroprotective role of IGF-1 in other pathological situations involved in HD progression. We have evaluated the neuroprotective effects of IGF-1 in vivo, using the 3-nitropropionic acid (3NP) rat model which replicates the mitochondrial dysfunction observed in HD. Continuous intracerebroventricular infusion of recombinant IGF-1 at a low dose (0.025 mu g/h for 5 days) did not alleviate motor impairment and weight loss induced by 3NP treatment. In addition, histological evaluation and quantification of DNA fragmentation evidenced no improvement in neuronal survival. Of interest, we found that a higher concentration of IGF- 1 (0.25 mu g/h) resulted in an exacerbation of 3NP toxicity on striatal neurons. These results suggest that intracerebral delivery of IGF-1 may not provide a fully effective therapeutic strategy for HD or other disorders involving mitochondrial impairment. (C) 2007 Elsevier Ireland Ltd. All rights reserved.

【 授权许可】

Free